Related Experiment Video
Updated: Aug 16, 2025
A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury
Gaia Pedriali1, Daniela Ramaccini1, Esmaa Bouhamida1
1Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy.
Insights
Myocardial ischemia-reperfusion injury (IRI) involves heart tissue damage during blood flow restoration. Mitochondria dysfunction significantly contributes to IRI, highlighting their role in heart disease pathogenesis.
Area of Science:
- Cardiology
- Cell Biology
- Mitochondrial Medicine
Background:
- Cardiovascular disease, particularly ischemic heart disease, is a leading global cause of mortality.
- Myocardial ischemia-reperfusion injury (IRI) remains a critical clinical challenge, complicating treatments for various heart conditions.
- While ischemia causes initial heart tissue damage, reperfusion, though necessary, can paradoxically exacerbate injury.
Purpose of the Study:
- To elucidate the pivotal role of mitochondria in the pathogenesis of myocardial ischemia-reperfusion injury (IRI).
- To investigate the alterations in mitochondrial quality control mechanisms during IRI.
- To highlight the significance of inter-organelle communication in IRI and explore mitochondria-targeting therapies.
Main Methods:
- Review of existing literature on myocardial IRI and mitochondrial function.
- Analysis of the impact of mitochondrial dynamics (fusion, fission, biogenesis, mitophagy) on IRI.
- Examination of the role of inter-organelle communication (mitochondria-plasma membrane, ER, nucleus) in IRI pathogenesis.
Main Results:
- Mitochondrial dysfunction is central to IRI, disrupting cellular homeostasis and survival.
- IRI is characterized by dysregulated mitochondrial quality control, including imbalanced fusion, fission, biogenesis, and mitophagy.
- Impaired communication between mitochondria and other organelles exacerbates IRI.
Conclusions:
- The mitochondrial network is crucial in the pathogenesis of myocardial IRI.
- Targeting mitochondria presents a promising therapeutic strategy for mitigating heart tissue damage following ischemia and reperfusion.
- Further research into mitochondria-centric therapies could revolutionize the management of IRI.
Abstract:
Cardiovascular disease is the most common cause of death worldwide and in particular, ischemic heart disease holds the most considerable position. Even if it has been deeply studied, myocardial ischemia-reperfusion injury (IRI) is still a side-effect of the clinical treatment for several heart diseases: ischemia process itself leads to temporary damage to heart tissue and obviously the recovery of blood flow is promptly required even if it worsens the ischemic injury. There is no doubt that mitochondria play a key role in pathogenesis of IRI: dysfunctions of these important organelles alter cell homeostasis and survival. It has been demonstrated that during IRI the system of mitochondrial quality control undergoes alterations with the disruption of the complex balance between the processes of mitochondrial fusion, fission, biogenesis and mitophagy. The fundamental role of mitochondria is carried out thanks to the finely regulated connection to other organelles such as plasma membrane, endoplasmic reticulum and nucleus, therefore impairments of these inter-organelle communications exacerbate IRI. This review pointed to enhance the importance of the mitochondrial network in the pathogenesis of IRI with the aim to focus on potential mitochondria-targeting therapies as new approach to control heart tissue damage after ischemia and reperfusion process.
Related Concept Videos
01:21Myocarditis I: Introduction
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:45Mitochondrial Membranes